Updated Jul 16, 2026
Keeney Adam has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-05 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 455 | $187.06 | $85K |
| 2026-05-05 | BIIB | BIOGEN INC. | M — Option exercise | 939 | $0.00 | |
| 2026-02-10 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 994 | $201.18 | $200K |
| 2026-02-10 | BIIB | BIOGEN INC. | M — Option exercise | 3.3K | $0.00 | |
| 2026-02-10 | BIIB | BIOGEN INC. | F — Tax withholding / forfeiture | 589 | $201.18 | $118K |
| 2026-02-10 | BIIB | BIOGEN INC. | M — Option exercise | 1.8K | $0.00 |
Keeney Adam is a corporate insider — currently tracked as Head of Corporate Development of BIOGEN INC. (BIIB). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Keeney Adam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.